Loading...
Loading...
Application 2025361702 · 00
| Application Number | 2025361702 |
| Registration Number | 1876170 |
| Status | 00 |
| Mark Type | madrid |
| Owner | Ultragenyx Pharmaceutical Inc. |
| Filed | 2025-09-18 |
| Registered | 2025-05-19 |
2025361702 has a current status of 00.
The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.
Pharmaceutical preparations for the treatment of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders.
Pharmaceutical, scientific, and medical research and development in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific and medical research, namely, providing patient data for research purposes in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing online non-downloadable software enabling input and collection of data and information on bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders for screening, diagnosis and treatment purposes.
Providing medical services in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; medical consulting services in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; healthcare services, namely, providing medical and healthcare information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders via an online database; medical information services in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal disease and disorder information based on collected patient data and information all for treatment and diagnostic purposes provided via a database.
| Name (romanised) | Ultragenyx Pharmaceutical Inc. |
This device mark (application number 2025361702) is a 00 trademark on the Japan Patent Office register, filed by Ultragenyx Pharmaceutical Inc. on 18 September 2025, with registration granted on 19 May 2025.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services), specifically covering: Pharmaceutical preparations for the treatment of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders.; Pharmaceutical, scientific, and medical research and development in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; scientific and medical research, namely, providing patient data for research purposes in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing medical research and scientific research information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; providing online non-downloadable software enabling input and collection of data and information on bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders for screening, diagnosis and treatment purposes.; Providing medical services in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; medical consulting services in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders; healthcare services, namely, providing medical and healthcare information in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders via an online database; medical information services in the field of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal disease and disorder information based on collected patient data and information all for treatment and diagnostic purposes provided via a database.
No — the Japan Patent Office records the status of Japanese trademark 2025361702 as 00.
Japanese trademark 2025361702 is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations for the treatment of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders. | Class 42: Pharmaceutical, scientific, and medical research and development in the field of bone, genetic, joint, metabolic, musculoskeletal, oste…
Japanese trademark 2025361702 was filed at the Japan Patent Office on 18 September 2025 and registered on 19 May 2025.
Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-18.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.